Skip to main content
. 2016 Apr 7;11(4):e0152060. doi: 10.1371/journal.pone.0152060

Table 3. Subgroup analyses for risks of postoperative complications according to the anesthetic method based on original data.

      TIVA, n (%) Isoflurane, n (%) OR or HR 95% CI P-value
Subgroup with high-risk (age≥70 or LV EF <45%) 70 282
Composite of in-hospital MAEs 21 (30) 73 (25.9) 1.23 0.69–2.18 0.49
In-hospital death 0 (0) 0 (0)
In-hospital myocardial infarction 3 (4.3) 19 (6.7) 0.62 0.18–2.16 0.45
In-hospital revascularization 0 (0) 3 (1)
In-hospital stroke 1 (1.4) 3 (1) 1.35 0.14–13.16 0.8
Prolonged mechanical ventilation (>72h) 0 (0) 6 (2.1)
Acute kidney injury 3 (4.3) 15 (5.3) 0.8 0.22–2.83 0.73
In-hospital new arrhythmia 17 (24.3) 49 (17.4) 1.53 0.82–2.86 0.19
One year MACCEs 5 (7.1) 23 (8.2) 1.54 0.23–1.86 0.42
Death 1 (1.4) 1 (0.4) 1
Myocardial infarction 3 (4.3) 17 (6) 1.63 0.18–2.06 0.43
Revascularization 0 3 (1)
Stroke 1 (1.4) 5 (1.8) 1.01 0.11–8.83 0.99
Other postoperative outcomes
Prolonged ICU stay (>72h) 14 (20) 38 (13.5) 1.61 0.82–3.16 0.17
In-hospital wound problem 2 (2.9) 8 (2.8) 1.01 0.21–4.85 0.99
Bleeding-related reoperation 2 (2.9) 3 (1.1) 2.74 0.45–16.69 0.28
Subgroup without high-risk (age<70 or LV EF ≥45%) 125 438
Composite of in-hospital MAEs 28 (22.4) 80 (18.3) 1.29 0.78–2.09 0.3
In-hospital death 0 (0) 1 (0.2)
In-hospital myocardial infarction 8 (6.4) 26 (5.9) 1.08 0.48–2.46 0.85
In-hospital revascularization 1 (0.8) 2 (0.5) 1.76 0.16–19.55 0.65
In-hospital stroke 1 (0.8) 5 (1.1) 0.7 0.08–6.03 0.74
Prolonged mechanical ventilation (>72h) 2 (1.6) 5 (1.1) 1.41 0.27–7.35 0.68
Acute kidney injury 2 (1.6) 12 (2.7) 0.58 0.13–2.61 0.48
In-hospital new arrhythmia 20 (16) 45 (10.3) 1.66 0.94–2.94 0.08
One year MACCEs 10 (8) 36 (8.2) 0.98 0.49–1.98 0.96
Death 1 (0.8) 1 (0.2) 3.54 0.22–56.52 0.37
Myocardial infarction 8 (6.4) 26 (5.9) 1.09 0.49–2.41 0.83
Revascularization 1 (0.8) 6 (1.4) 0.58 0.07–4.85 0.62
Stroke 1 (0.8) 5 (1.1) 0.7 0.08–6.01 0.75
Other postoperative outcomes
Prolonged ICU stay (>72h) 9 (7.2) 31 (7.1) 1.02 0.47–2.20 0.96
In-hospital wound problem 3 (2.4) 8 (1.8) 1.32 0.35–5.06 0.68
Bleeding-related reoperation 2 (1.6) 7 (1.6) 1 0.21–4.88 0.99
Subgroup with diabetes mellitus or hyperglycemia 104 397
Composite of in-hospital MAEs 27 (26) 92 (23.2) 1.16 0.71–1.91 0.55
In-hospital death 0 (0) 0 (0)
In-hospital myocardial infarction 4 (3.9) 23 (5.8) 0.65 0.22–1.92 0.44
In-hospital revascularization 1 (1) 3 (0.8) 1.28 0.13–12.39 0.83
In-hospital stroke 1 (1) 7 (1.8) 0.54 0.07–4.45 0.57
Prolonged mechanical ventilation (>72h) 2 (1.9) 7 (1.8) 1.09 0.22–5.34 0.91
Acute kidney injury 3 (2.9) 19 (4.8) 0.59 0.17–2.04 0.4
In-hospital new arrhythmia 22 (21.1) 59 (14.9) 1.54 0.89–2.65 0.12
One year MACCEs 6 (5.8) 32 (8.1) 1.4 0.3–1.71 0.45
Death 1 (1) 2 (0.5) 0.51 0.18–21.64 0.58
Myocardial infarction 4 (3.9) 23 (5.8) 1.5 0.2–1.9 0.46
Revascularization 1 (1) 4 (1) 1.05 0.11–8.52 0.97
Stroke 1 (1) 8 (2) 2.13 0.06–3.76 0.48
Other postoperative outcomes
Prolonged ICU stay (>72h) 17 (16.4) 43 (10.8) 1.61 0.88–2.96 0.13
In-hospital wound problem 3 (2.9) 10 (2.5) 1.15 0.31–4.26 0.83
Bleeding-related reoperation 2 (1.9) 7 (1.8) 1.09 0.22–5.34 0.91
Subgroup without diabetes mellitus or hyperglycemia 91 323
Composite of in-hospital MAEs 22 (24.2) 61 (18.9) 1.37 0.79–2.39 0.27
In-hospital death 0 (0) 0 (0)
In-hospital myocardial infarction 7 (7.7) 22 (6.8) 1.14 0.47–2.76 0.77
In-hospital revascularization 0 (0) 2 (0.6)
In-hospital stroke 1 (1.1) 1 (0.3) 3.58 0.22–57.77 0.37
Prolonged mechanical ventilation (>72h) 0 (0) 4 (1.2)
Acute kidney injury 2 (2.2) 8 (2.5) 0.89 0.19–4.24 0.88
In-hospital new arrhythmia 15 (16.5) 35 (10.8) 1.62 0.84–3.13 0.15
One year MACCEs 8 29 0.99 0.46–2.18 0.99
Death 0 (0) 0 (0)
Myocardial infarction 7 (7.7) 23 (7.1) 1.1 0.47–2.57 0.82
Revascularization 0 (0) 6 (1.9)
Stroke 1 (1.1) 1 (0.3) 3.58 0.22–57.29 0.37
Other postoperative outcomes
Prolonged ICU stay (>72h) 6 (6.6) 26 (8.05) 0.81 0.32–2.02 0.65
In-hospital wound problem 2 (2.2) 6 (1.9) 1.19 0.24–5.98 0.84
    Bleeding-related reoperation 2 (2.2) 3 (0.9) 2.4 0.39–14.57 0.34

TIVA indicates propofol-remifentanil total intravenous anesthesia; OR, odds ratio; HR, hazard ratio; CI, confidence interval; LV EF, left ventricular ejection fraction; MAEs, major adverse events; MACCEs, major adverse cardiovascular and cerebral events; ICU, intensive care unit.